67 related articles for article (PubMed ID: 21937807)
21. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
[TBL] [Abstract][Full Text] [Related]
22. [Effect of combination of herbimycin A, an inhibitor of tyrosine kinase, and chemotherapeutic agents on apoptosis of K562 cells].
Ren H; Chen S; Lu D
Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):227-30. PubMed ID: 15622750
[TBL] [Abstract][Full Text] [Related]
23. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
24. Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change.
Rahmani M; Reese E; Dai Y; Bauer C; Kramer LB; Huang M; Jove R; Dent P; Grant S
Mol Pharmacol; 2005 Apr; 67(4):1166-76. PubMed ID: 15625278
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
26. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
[TBL] [Abstract][Full Text] [Related]
27. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
28. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
La Rosée P; Jia T; Demehri S; Härtel N; de Vries P; Bonham L; Hollenback D; Singer JW; Melo JV; Druker BJ; Deininger MW
Clin Cancer Res; 2006 Nov; 12(21):6540-6. PubMed ID: 17085669
[TBL] [Abstract][Full Text] [Related]
29. [Imatinib induces c-kit positive myeloma cells apoptosis].
Li J; Huang BH; Zhao Y; Luo SK
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):230-3. PubMed ID: 18843975
[TBL] [Abstract][Full Text] [Related]
30. Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562.
Zhang K; Xu J; Huang X; Wu L; Wen C; Hu Y; Su Y; Chen Y; Zhang Z
Cancer Chemother Pharmacol; 2007 Sep; 60(4):581-7. PubMed ID: 17435997
[TBL] [Abstract][Full Text] [Related]
31. Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells.
Baran Y; Oztekin C; Bassoy EY
Cancer Invest; 2010 Jul; 28(6):623-8. PubMed ID: 20307198
[TBL] [Abstract][Full Text] [Related]
32. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
[TBL] [Abstract][Full Text] [Related]
33. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
[TBL] [Abstract][Full Text] [Related]
34. [Effect of imatinib at different concentrations on rat C6 glioma cell apoptosis and cell cycle].
Yang L; Xu ZY; Chen XH; Wang KW; Li GF; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1089-91. PubMed ID: 20501402
[TBL] [Abstract][Full Text] [Related]
35. Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells.
Du R; Liu Z; Hou X; Fu G; An N; Wang L
Mol Med Rep; 2016 Jun; 13(6):5045-52. PubMed ID: 27121018
[TBL] [Abstract][Full Text] [Related]
36. [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T].
Zhang PY; Li BJ; Su XD; Wen ZS; Zhao JM; Zhang LJ; Long H; Rong TH
Ai Zheng; 2006 Apr; 25(4):456-60. PubMed ID: 16613680
[TBL] [Abstract][Full Text] [Related]
37. Effect of imatinib mesylate combined with granulocyte colony-stimulating factor on leukaemic blast cells derived from advanced-stage chronic myelogenous leukaemia patients.
Ota S; Musashi M; Kondo K; Toyoshima N; Toubai T; Onozawa M; Mori A; Hashino S; Tanaka J; Matsuno K; Imamura M; Asaka M
Acta Haematol; 2006; 116(1):8-18. PubMed ID: 16809884
[TBL] [Abstract][Full Text] [Related]
38. Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells.
Mlejnek P; Dolezel P; Faber E; Kosztyu P
Ann Hematol; 2011 Jul; 90(7):837-42. PubMed ID: 21225261
[TBL] [Abstract][Full Text] [Related]
39. [Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells].
Liu H; Fu RY; Li FY; Zhu YP; Wang XY; Mao YQ; Wu XZ; Zhou CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):964-8. PubMed ID: 16403260
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
Tauchi T; Nakajima A; Sashida G; Shimamoto T; Ohyashiki JH; Abe K; Yamamoto K; Ohyashiki K
Clin Cancer Res; 2002 Nov; 8(11):3341-7. PubMed ID: 12429620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]